Search - tctmd.com

Displaying 421 - 440 of 1424

Sort: Relevancy | Date

Presentation Aortovascular 2015

Peripheral Artery Disease: A Primer on Scope, Identification and Testing

Presenter: Timothy Crimmins

September 18, 2015

News Daily News

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Yael L. Maxwell

September 18, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

RECLOSE-3: Cambiar a Clopidogrel a No Respondedores al Prasugrel Reduce la Mortalidad Post-PCI

Yael L. Maxwell

September 18, 2015

News Daily News

RECLOSE-3：对氯吡格雷无反应者改用普拉格雷可降低PCI术后死亡率

Yael L. Maxwell

September 18, 2015

News Industry News

Cook Medical Receives FDA Approval for the Zenith Alpha™ Thoracic Endovascular Graft

September 18, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

HeartStitch® Brings New Technology to Astana to Treat Structural Heart Disease

September 11, 2015

News Daily News

Short-term Readmission Rates Similar After TAVR vs SAVR

Todd Neale

September 10, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Industry News

Boston Heart Reaches Milestone in Statin Intolerance Testing

September 08, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

L.A. McKeown

August 30, 2015

News Conference News ESC 2015

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Yael L. Maxwell

August 30, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

Advertisement

Peripheral Artery Disease: A Primer on Scope, Identification and Testing

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

RECLOSE-3: Cambiar a Clopidogrel a No Respondedores al Prasugrel Reduce la Mortalidad Post-PCI

RECLOSE-3：对氯吡格雷无反应者改用普拉格雷可降低PCI术后死亡率

Cook Medical Receives FDA Approval for the Zenith Alpha™ Thoracic Endovascular Graft

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

HeartStitch® Brings New Technology to Astana to Treat Structural Heart Disease

Short-term Readmission Rates Similar After TAVR vs SAVR

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

Boston Heart Reaches Milestone in Statin Intolerance Testing

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content